NO975680L - Oralt, farmasöytisk preparat av piperidinoalkanol-forbindelser i opplösningsform - Google Patents

Oralt, farmasöytisk preparat av piperidinoalkanol-forbindelser i opplösningsform

Info

Publication number
NO975680L
NO975680L NO975680A NO975680A NO975680L NO 975680 L NO975680 L NO 975680L NO 975680 A NO975680 A NO 975680A NO 975680 A NO975680 A NO 975680A NO 975680 L NO975680 L NO 975680L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
oral pharmaceutical
solution form
piperidinoalkanol compounds
piperidinoalkanol
Prior art date
Application number
NO975680A
Other languages
English (en)
Other versions
NO975680D0 (no
NO318029B1 (no
Inventor
Thomas T Ortyl
Paul F Skultety
Gail H Hurst
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO975680D0 publication Critical patent/NO975680D0/no
Publication of NO975680L publication Critical patent/NO975680L/no
Publication of NO318029B1 publication Critical patent/NO318029B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
NO19975680A 1995-06-06 1997-12-05 Oralt, farmasoytisk preparat av piperidinoalkanol-forbindelser i opplosningsform, samt fremgangsmate for fremstilling derav NO318029B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/469,392 US5574045A (en) 1995-06-06 1995-06-06 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
PCT/US1996/005968 WO1996039139A1 (en) 1995-06-06 1996-04-30 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form

Publications (3)

Publication Number Publication Date
NO975680D0 NO975680D0 (no) 1997-12-05
NO975680L true NO975680L (no) 1998-02-05
NO318029B1 NO318029B1 (no) 2005-01-24

Family

ID=23863607

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975680A NO318029B1 (no) 1995-06-06 1997-12-05 Oralt, farmasoytisk preparat av piperidinoalkanol-forbindelser i opplosningsform, samt fremgangsmate for fremstilling derav

Country Status (22)

Country Link
US (1) US5574045A (no)
EP (1) EP0831820B1 (no)
JP (1) JP4091655B2 (no)
KR (1) KR100509316B1 (no)
CN (1) CN1139386C (no)
AR (1) AR002191A1 (no)
AT (1) ATE256465T1 (no)
AU (1) AU707218B2 (no)
CA (1) CA2218643C (no)
DE (1) DE69631132T2 (no)
DK (1) DK0831820T3 (no)
ES (1) ES2211954T3 (no)
HU (1) HU227710B1 (no)
IL (1) IL118525A (no)
MX (1) MX9709453A (no)
NO (1) NO318029B1 (no)
NZ (1) NZ307370A (no)
PT (1) PT831820E (no)
SI (1) SI0831820T1 (no)
TW (1) TW460283B (no)
WO (1) WO1996039139A1 (no)
ZA (1) ZA964517B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045722A1 (en) * 1994-05-18 2003-03-06 Henton Daniel R. Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
DE69527429T2 (de) * 1994-05-18 2003-03-20 Aventis Pharma Inc Verfahren zur herstellung von wasserfreien und hydrat-formen von antihistaminischen piperinderivaten, polymerphe und pseudomorphe davon
KR100405116B1 (ko) * 1995-02-28 2004-02-05 아벤티스 파마슈티칼스 인크. 피페리디노알칸올화합물에대한약제학적조성물
ES2107375B1 (es) * 1995-08-01 1998-07-01 Almirall Prodesfarma Sa Formulaciones farmaceuticas liquidas de ebastina por via oral.
US6451815B1 (en) 1997-08-14 2002-09-17 Aventis Pharmaceuticals Inc. Method of enhancing bioavailability of fexofenadine and its derivatives
TR200000517T2 (tr) * 1997-08-26 2000-08-21 Hoechst Marion Roussel, Inc. Piperidinoalkanol-Konjesyon azaltıcıdan oluşan kombinasyona yönelik farmasötik kompozisyon.
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
US6613906B1 (en) 2000-06-06 2003-09-02 Geneva Pharmaceuticals, Inc. Crystal modification
US20060205752A1 (en) * 2005-03-14 2006-09-14 Keith Whitehead Stabilized hydrocodone pharmaceutical compositions with ethylenediaminetetraacetic acid

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives
US3806526A (en) * 1972-01-28 1974-04-23 Richardson Merrell Inc 1-aroylalkyl-4-diphenylmethyl piperidines
US3966949A (en) * 1973-10-12 1976-06-29 Richardson-Merrell Inc. Pharmaceutical compositions and preparing same
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4285958A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkylene ketones, pharmaceutical compositions thereof and method of use thereof
US4285957A (en) * 1979-04-10 1981-08-25 Richardson-Merrell Inc. 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
EP0111114A3 (de) * 1982-11-06 1985-10-09 Telefonbau und Normalzeit GmbH Schaltungsanordnung für eine Fernsprechvermittlungsanlage, insbesondere Fernsprechnebenstellenanlage mit zusätzlichem Datenverkehr
DK164642C (da) * 1984-08-30 1992-12-14 Merrell Dow Pharma Farmaceutisk middel indeholdende terfenadin i form af en varmsmelte paafyldt paa kapsler
US4929605A (en) * 1987-10-07 1990-05-29 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol derivatives
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
ZA90341B (en) * 1989-01-23 1990-10-31 Merrell Dow Pharma Liquid pharmaceutical composition for piperidinoalkanol derivatives
US4966061A (en) * 1989-03-27 1990-10-30 Riera John F Tube cutting apparatus

Also Published As

Publication number Publication date
KR100509316B1 (ko) 2005-11-25
WO1996039139A1 (en) 1996-12-12
JP4091655B2 (ja) 2008-05-28
ATE256465T1 (de) 2004-01-15
JPH11506115A (ja) 1999-06-02
CA2218643C (en) 2001-12-11
NZ307370A (en) 1999-07-29
DK0831820T3 (da) 2004-04-13
EP0831820B1 (en) 2003-12-17
CN1187125A (zh) 1998-07-08
KR19990022504A (ko) 1999-03-25
CA2218643A1 (en) 1996-12-12
MX9709453A (es) 1998-02-28
AR002191A1 (es) 1998-01-07
AU707218B2 (en) 1999-07-08
DE69631132D1 (de) 2004-01-29
US5574045A (en) 1996-11-12
EP0831820A1 (en) 1998-04-01
NO975680D0 (no) 1997-12-05
HU227710B1 (en) 2011-12-28
PT831820E (pt) 2004-05-31
AU5669596A (en) 1996-12-24
HUP9802096A3 (en) 1999-06-28
NO318029B1 (no) 2005-01-24
ES2211954T3 (es) 2004-07-16
CN1139386C (zh) 2004-02-25
IL118525A (en) 2001-07-24
TW460283B (en) 2001-10-21
HUP9802096A2 (hu) 1999-01-28
SI0831820T1 (en) 2004-04-30
IL118525A0 (en) 1996-10-16
DE69631132T2 (de) 2004-08-19
ZA964517B (en) 1996-12-09

Similar Documents

Publication Publication Date Title
NO973938D0 (no) Farmasöytisk preparat av piperdinoalkanolforbindelser
NO973612L (no) Nytt farmasöytisk preparat
ATE206924T1 (de) Oral anzuwendende arzneizubereitung enthaltend olanzapin
DK0754061T3 (da) Ny oral farmaceutisk doseringsform
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
EE9700031A (et) Pürido-liitunud tienüül- ja furanüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
DE69630145D1 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE59712959D1 (de) Orale pharmazeutische zubereitung enthaltend ibandronat
NO996372L (no) Fast farmasøytisk preparat inneholdende benzofuanderivater
NO963032D0 (no) Oralt preparat
NO970036D0 (no) Nytt oralt, farmasöytisk preparat inneholdende magnesiumsalt av omeprazol
NO953367D0 (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
NO20041007L (no) Anvendelse av oksypurin-nukleosider for fremstilling av et farmasoytisk preparat
DE69608680T2 (de) Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
NO975680L (no) Oralt, farmasöytisk preparat av piperidinoalkanol-forbindelser i opplösningsform
NO973610D0 (no) Nytt farmasöytisk preparat
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
NO973611D0 (no) Nytt farmasöytisk preparat
FI951155A (fi) Farmaseuttinen valmiste
EE9600021A (et) Asendatud indoolderivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks, nimetatud ühendeid sisaldavad ravimid ja nende valmistamismeetod
NO20003393D0 (no) FremgangsmÕte for fremstilling av en farmasøytisk formulering
FI961717A (fi) Menetelmä oraalisten, kinoloneja sisältävien valmisteiden valmistamiseksi
NO20003284L (no) Farmasøytisk preparat for oral administrering
SE9402433D0 (sv) New oral pharmaceutical dosage form

Legal Events

Date Code Title Description
MK1K Patent expired